Elizabeth A. Barrett - Net Worth and Insider Trading
Elizabeth A. Barrett Net Worth
The estimated net worth of Elizabeth A. Barrett is at least $4 Million dollars as of 2024-11-13. Elizabeth A. Barrett is the CEO of UroGen Pharma Ltd and owns about 308,358 shares of UroGen Pharma Ltd (URGN) stock worth over $4 Million. Details can be seen in Elizabeth A. Barrett's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Elizabeth A. Barrett has not made any transactions after 2022-01-31 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Elizabeth A. Barrett
Elizabeth A. Barrett Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Elizabeth A. Barrett owns 3 companies in total, including UroGen Pharma Ltd (URGN) , Allogene Therapeutics Inc (ALLO) , and Science 37 Holdings Inc (SNCE) .
Click here to see the complete history of Elizabeth A. Barrett’s form 4 insider trades.
Insider Ownership Summary of Elizabeth A. Barrett
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| URGN | UroGen Pharma Ltd | 2022-01-31 | Chief Executive Officer |
| ALLO | Allogene Therapeutics Inc | 2021-07-30 | director |
| SNCE | Science 37 Holdings Inc | 2020-11-20 | director |
Elizabeth A. Barrett Latest Holdings Summary
Elizabeth A. Barrett currently owns a total of 1 stock. Elizabeth A. Barrett owns 308,358 shares of UroGen Pharma Ltd (URGN) as of January 31, 2022, with a value of $4 Million.
Latest Holdings of Elizabeth A. Barrett
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| URGN | UroGen Pharma Ltd | 2022-01-31 | 308,358 | 12.36 | 3,811,305 |
Holding Weightings of Elizabeth A. Barrett
Elizabeth A. Barrett Form 4 Trading Tracker
According to the SEC Form 4 filings, Elizabeth A. Barrett has made a total of 6 transactions in UroGen Pharma Ltd (URGN) over the past 5 years, including 4 buys and 2 sells. The most-recent trade in UroGen Pharma Ltd is the sale of 8,195 shares on January 31, 2022, which brought Elizabeth A. Barrett around $62,118.
Insider Trading History of Elizabeth A. Barrett
- 1
Elizabeth A. Barrett Trading Performance
GuruFocus tracks the stock performance after each of Elizabeth A. Barrett's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Elizabeth A. Barrett is 4.55%. GuruFocus also compares Elizabeth A. Barrett's trading performance to market benchmark return within the same time period. The performance of stocks bought by Elizabeth A. Barrett within 3 months outperforms 0 times out of 4 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Elizabeth A. Barrett's insider trading performs compared to the benchmark.
Performance of Elizabeth A. Barrett
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 17.85 | | | | | |
| Relative Return to S&P 500(%) | 14.6 | | | | | |
Elizabeth A. Barrett Ownership Network
Ownership Network List of Elizabeth A. Barrett
Ownership Network Relation of Elizabeth A. Barrett
Elizabeth A. Barrett Owned Company Details
What does UroGen Pharma Ltd do?
Who are the key executives at UroGen Pharma Ltd?
Elizabeth A. Barrett is the Chief Executive Officer of UroGen Pharma Ltd. Other key executives at UroGen Pharma Ltd include General Counsel Jason Drew Smith , Chief Medical Officer Mark Schoenberg , and Chief Financial Officer Dong Kim .
UroGen Pharma Ltd (URGN) Insider Trades Summary
Over the past 18 months, Elizabeth A. Barrett made no insider transaction in UroGen Pharma Ltd (URGN). Other recent insider transactions involving UroGen Pharma Ltd (URGN) include a net sale of 25,590 shares made by Mark Schoenberg , and a net sale of 15,307 shares made by Jason Drew Smith .
In summary, during the past 3 months, insiders sold 2,380 shares of UroGen Pharma Ltd (URGN) in total and bought 0 shares, with a net sale of 2,380 shares. During the past 18 months, 40,897 shares of UroGen Pharma Ltd (URGN) were sold and 0 shares were bought by its insiders, resulting in a net sale of 40,897 shares.
UroGen Pharma Ltd (URGN)'s detailed insider trading history can be found in Insider Trading Tracker table.
UroGen Pharma Ltd Insider Transactions
Elizabeth A. Barrett Mailing Address
Above is the net worth, insider trading, and ownership report for Elizabeth A. Barrett. You might contact Elizabeth A. Barrett via mailing address: C/o Urogen Pharma Ltd., 9 Ha'ta'asiya Street, Ra'anana L3 4365007.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
